Literature DB >> 17537948

Vaginal Staphylococcus aureus superantigen profile shift from 1980 and 1981 to 2003, 2004, and 2005.

Patrick M Schlievert1, Laura C Case, Kristi L Strandberg, Timothy J Tripp, Ying-Chi Lin, Marnie L Peterson.   

Abstract

We determined vaginal Staphylococcus aureus superantigens. Staphylococci were quantified from tampons/diaphragms in 2003 to 2005, with counts compared to those determined in 1980 and 1981. In 2003 to 2005, more women were colonized than in 1980 and 1981 (23 versus 12%). Enterotoxins G and I and enterotoxin-like superantigens M and N declined, but enterotoxin-like superantigens K, L, and Q increased.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17537948      PMCID: PMC1951268          DOI: 10.1128/JCM.02295-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  39 in total

1.  Standard nomenclature for the superantigens expressed by Staphylococcus.

Authors:  Gerard Lina; Gregory A Bohach; Sean P Nair; Keiichi Hiramatsu; Evelyne Jouvin-Marche; Roy Mariuzza
Journal:  J Infect Dis       Date:  2004-05-26       Impact factor: 5.226

2.  Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St. Paul, Minnesota, during the 2000-2003 surveillance period.

Authors:  Patrick M Schlievert; Timothy J Tripp; Marnie L Peterson
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

3.  The effect of antibiotic prophylaxis on patients undergoing vaginal operations. II. Alterations of microbial flora.

Authors:  M J Ohm; R P Galask
Journal:  Am J Obstet Gynecol       Date:  1975-11-15       Impact factor: 8.661

Review 4.  Vaginal microbial flora: composition and influences of host physiology.

Authors:  B Larsen; R P Galask
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

5.  A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates.

Authors:  M S Bergdoll; B A Crass; R F Reiser; R N Robbins; J P Davis
Journal:  Lancet       Date:  1981-05-09       Impact factor: 79.321

6.  Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome.

Authors:  P M Schlievert; K N Shands; B B Dan; G P Schmid; R D Nishimura
Journal:  J Infect Dis       Date:  1981-04       Impact factor: 5.226

7.  Detection of Staphylococcus aureus biofilm on tampons and menses components.

Authors:  Richard H Veeh; Mark E Shirtliff; Jill R Petik; Janine A Flood; Catherine C Davis; Jon L Seymour; Melanie A Hansmann; Kathy M Kerr; Mark E Pasmore; John W Costerton
Journal:  J Infect Dis       Date:  2003-07-25       Impact factor: 5.226

8.  Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases.

Authors:  K N Shands; G P Schmid; B B Dan; D Blum; R J Guidotti; N T Hargrett; R L Anderson; D L Hill; C V Broome; J D Band; D W Fraser
Journal:  N Engl J Med       Date:  1980-12-18       Impact factor: 91.245

9.  Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention.

Authors:  J P Davis; P J Chesney; P J Wand; M LaVenture
Journal:  N Engl J Med       Date:  1980-12-18       Impact factor: 91.245

10.  Desquamative inflammatory vaginitis: an exploratory case-control study.

Authors:  E Claire Newbern; Betsy Foxman; Deborah Leaman; Jack D Sobel
Journal:  Ann Epidemiol       Date:  2002-07       Impact factor: 3.797

View more
  11 in total

1.  Staphylococcus aureus exotoxins are present in vivo in tampons.

Authors:  Patrick M Schlievert; Kimberly A Nemeth; Catherine C Davis; Marnie L Peterson; Bruce E Jones
Journal:  Clin Vaccine Immunol       Date:  2010-03-24

2.  Superantigens of Staphylococcus aureus from patients with diabetic foot ulcers.

Authors:  Bao G Vu; Christopher S Stach; Wilmara Salgado-Pabón; Daniel J Diekema; Sue E Gardner; Patrick M Schlievert
Journal:  J Infect Dis       Date:  2014-06-20       Impact factor: 5.226

3.  Effect of non-absorbent intravaginal menstrual/contraceptive products on Staphylococcus aureus and production of the superantigen TSST-1.

Authors:  Patrick M Schlievert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-18       Impact factor: 3.267

4.  Proinflammatory exoprotein characterization of toxic shock syndrome Staphylococcus aureus.

Authors:  Ying-Chi Lin; Michele J Anderson; Petra L Kohler; Kristi L Strandberg; Michael E Olson; Alexander R Horswill; Patrick M Schlievert; Marnie L Peterson
Journal:  Biochemistry       Date:  2011-07-21       Impact factor: 3.162

5.  New insights into the prevention of staphylococcal infections and toxic shock syndrome.

Authors:  Ying-Chi Lin; Marnie L Peterson
Journal:  Expert Rev Clin Pharmacol       Date:  2010-11-01       Impact factor: 5.045

Review 6.  Gram-positive bacterial superantigen outside-in signaling causes toxic shock syndrome.

Authors:  Amanda J Brosnahan; Patrick M Schlievert
Journal:  FEBS J       Date:  2011-05-19       Impact factor: 5.542

Review 7.  Device-Associated Menstrual Toxic Shock Syndrome.

Authors:  Patrick M Schlievert; Catherine C Davis
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

8.  Superantigen profile of Staphylococcus aureus isolates from patients with steroid-resistant atopic dermatitis.

Authors:  Patrick M Schlievert; Laura C Case; Kristi L Strandberg; Bea B Abrams; Donald Y M Leung
Journal:  Clin Infect Dis       Date:  2008-05-15       Impact factor: 9.079

Review 9.  Staphylococcal and streptococcal superantigen exotoxins.

Authors:  Adam R Spaulding; Wilmara Salgado-Pabón; Petra L Kohler; Alexander R Horswill; Donald Y M Leung; Patrick M Schlievert
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

10.  Determining the Presence of Superantigens in Coagulase Negative Staphylococci from Humans.

Authors:  Christopher S Stach; Bao G Vu; Patrick M Schlievert
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.